2020
18 F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of suspected paraneoplastic syndromes: A retrospective analysis
Bresler R, Schroeder H, Chow D, Lim R. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of suspected paraneoplastic syndromes: A retrospective analysis. World Journal Of Nuclear Medicine 2020, 19: 124-130. PMID: 32939199, PMCID: PMC7478297, DOI: 10.4103/wjnm.wjnm_48_19.Peer-Reviewed Original ResearchF-FDG PET/CTSuspected paraneoplastic syndromeNegative predictive valueParaneoplastic syndromeF-FDGF-fluorodeoxyglucose positron emission tomography/computed tomographyWhole-body <sup>18</sup>F-FDG PET/CTClinical presentation of tumorsPositron emission tomography/computed tomographySingle-center retrospective studyPredictive valueEmission tomography/computed tomographyPresentation of tumorsFollow-up timeElectronic chart reviewPositive predictive valueFollow-up periodSigns and symptomsAncillary diagnostic proceduresDiagnostic imaging toolTomography/computed tomographyF-fluorodeoxyglucoseClinical presentationDiagnostic challengeRetrospective study
2014
[18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal Spine
Cheney M, Chen Y, Lim R, Winrich B, Grosu A, Trofimov A, Depauw N, Shih H, Schwab J, Hornicek F, DeLaney T. [18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal Spine. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: 1030-1036. PMID: 25539367, PMCID: PMC4280072, DOI: 10.1016/j.ijrobp.2014.08.016.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCell HypoxiaChordomaFeasibility StudiesFemaleHumansMaleMiddle AgedMisonidazoleMultimodal ImagingNeoplasm Recurrence, LocalPhotonsPilot ProjectsPositron-Emission TomographyProspective StudiesProton TherapyRadiopharmaceuticalsRadiotherapy DosageRelative Biological EffectivenessSacrococcygeal RegionSpinal NeoplasmsTomography, X-Ray ComputedTumor BurdenConceptsHypoxic subvolumesGross tumor volumeFMISO PET/CTRadiation therapyLocal recurrenceTumor volumeSacrococcygeal spinePositron emission tomography/computed tomographyRT dose escalationStage T2 tumorsEmission tomography/computed tomographyStandardized uptake valueMedian follow-upTreatment of chordomasChanges to treatmentVisualization of tumor hypoxiaDose escalationT2 tumorsTomography/computed tomographyMetastatic diseaseRecurrent chordomaUptake valueClinical characteristicsTumor hypoxiaFollow-up